![Erin Borger](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Erin Borger
Chief Executive Officer at ExThera Medical Corp.
Erin Borger active positions
Companies | Position | Start | End |
---|---|---|---|
ExThera Medical Corp.
![]() ExThera Medical Corp. Medical/Nursing ServicesHealth Services ExThera Medical Corp. develops medical devices that address unmet clinical needs in the treatment of bloodstream infections and pathogen-reduction in blood banking. The company develops Seraph Microbind Affinity Blood Filter (Seraph), which captures and removes normal and drug-resistant bacteria, viruses, toxins, and pro-inflammatory cytokines from human blood; and offers solution for use in a dialysis, such as extracorporeal circuit for treating existing bloodstream infections. The company was founded in 2007 and is headquartered in Martinez, CA. | Director/Board Member | - | - |
Chief Executive Officer | 14/11/2023 | - |
Career history of Erin Borger
Former positions of Erin Borger
Companies | Position | Start | End |
---|---|---|---|
LONGEVERON INC. | Director/Board Member | 11/02/2021 | 08/06/2023 |
Independent Dir/Board Member | 11/02/2021 | 08/06/2023 | |
National Parkinson Foundation, Inc. | Director/Board Member | 11/01/2014 | - |
Training of Erin Borger
Wofford College | Undergraduate Degree |
Statistics
International
United States | 5 |
Operational
Director/Board Member | 3 |
Independent Dir/Board Member | 1 |
Undergraduate Degree | 1 |
Sectoral
Health Technology | 3 |
Consumer Services | 2 |
Health Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
LONGEVERON INC. | Health Technology |
Private companies | 2 |
---|---|
National Parkinson Foundation, Inc. | Health Technology |
ExThera Medical Corp.
![]() ExThera Medical Corp. Medical/Nursing ServicesHealth Services ExThera Medical Corp. develops medical devices that address unmet clinical needs in the treatment of bloodstream infections and pathogen-reduction in blood banking. The company develops Seraph Microbind Affinity Blood Filter (Seraph), which captures and removes normal and drug-resistant bacteria, viruses, toxins, and pro-inflammatory cytokines from human blood; and offers solution for use in a dialysis, such as extracorporeal circuit for treating existing bloodstream infections. The company was founded in 2007 and is headquartered in Martinez, CA. | Health Services |
- Stock Market
- Insiders
- Erin Borger
- Experience